Boston Scientific Corporation Posts Loss on Restructuring, Lawsuits
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Medical device maker Boston Scientific Corp (BSX.N) posted a first-quarter loss on Thursday as it took $578 million in charges for litigation and restructuring, including reducing its workforce. Excluding the one-time charges, it had a profit of 16 cents per share, up a penny from a year earlier. The company, a maker of heart stents, pacemakers, surgical instruments and other medical devices, has said it will cut more jobs this year in its ongoing restructuring. It has said the restructuring will result in total pretax charges of $300 million to $355 million.
Help employers find you! Check out all the jobs and post your resume.
Medical device maker Boston Scientific Corp (BSX.N) posted a first-quarter loss on Thursday as it took $578 million in charges for litigation and restructuring, including reducing its workforce. Excluding the one-time charges, it had a profit of 16 cents per share, up a penny from a year earlier. The company, a maker of heart stents, pacemakers, surgical instruments and other medical devices, has said it will cut more jobs this year in its ongoing restructuring. It has said the restructuring will result in total pretax charges of $300 million to $355 million.
Help employers find you! Check out all the jobs and post your resume.